• Home
  • Search Results
  • Actin Assembly around the Shigella-Containing Vacuole Promotes Successful Infection.

Actin Assembly around the Shigella-Containing Vacuole Promotes Successful Infection.

Cell reports (2020-05-14)
Sonja Kühn, John Bergqvist, Magdalena Gil, Camila Valenzuela, Laura Barrio, Stéphanie Lebreton, Chiara Zurzolo, Jost Enninga

The enteroinvasive bacterium Shigella flexneri forces its uptake into non-phagocytic host cells through the translocation of T3SS effectors that subvert the actin cytoskeleton. Here, we report de novo actin polymerization after cellular entry around the bacterium-containing vacuole (BCV) leading to the formation of a dynamic actin cocoon. This cocoon is thicker than any described cellular actin structure and functions as a gatekeeper for the cytosolic access of the pathogen. Host CDC42, TOCA-1, N-WASP, WIP, the Arp2/3 complex, cortactin, coronin, and cofilin are recruited to the actin cocoon. They are subverted by T3SS effectors, such as IpgD, IpgB1, and IcsB. IcsB immobilizes components of the actin polymerization machinery at the BCV dependent on its fatty acyltransferase activity. This represents a unique microbial subversion strategy through localized entrapment of host actin regulators causing massive actin assembly. We propose that the cocoon promotes subsequent invasion steps for successful Shigella infection.

Product Number
Product Description

Poly-L-lysine solution, 0.01%, sterile-filtered, BioReagent, suitable for cell culture
meso-Tetraphenylporphyrin, BioReagent, suitable for fluorescence, ≥99.0% (HPLC)
Monoclonal Anti-β-Actin antibody produced in mouse, clone AC-74, ascites fluid
Rac1 Inhibitor - CAS 1177865-17-6 - Calbiochem, Rac1 Inhibitor, CAS 1177865-17-6, is a cell-permeable, reversible inhibitor of Rac1 GDP/GTP exchange. Interferes with the interaction between Rac1 and Rac-specific GEFs Trio and Tiam1 (IC₅₀ ~50 µM).
Kanamycin sulfate from Streptomyces kanamyceticus, powder, BioReagent, suitable for cell culture, suitable for plant cell culture
Ampicillin, anhydrous, 96.0-102.0% (anhydrous basis)
MISSION® esiRNA, targeting human SEPT7
SMIFH2, ≥98% (HPLC)
CK-666, ≥98% (HPLC), powder
BRAND® 96-well microplate, U-bottom, round bottom, non-sterile